Sutro Achieves $10 Million Milestone Payment from Celgene

San Francisco, CA, December 19, 2018 –(PRWirePro.com)– Sutro Biopharma, Inc. (NASDAQ:STRO), today announced that the company earned $10 million in a milestone payment from Celgene triggered by the successful development of a dry powder XtractCFTM formulation, using spray drying technology, which is well established in the pharmaceutical industry. Dried XtractCFTM Read more…

PR Distribution Services
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.